Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100
Portfolio Pulse from Benzinga Neuro
Senator Bernie Sanders criticized Novo Nordisk for the high price of its diabetes drug, Ozempic, in the U.S., highlighting that it can be sold for less than $100 but costs Americans nearly $1,000. Sanders attributes this to corporate greed and urges Novo Nordisk to lower prices.
September 23, 2024 | 2:19 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Novo Nordisk faces criticism from Bernie Sanders over the high U.S. prices of its drug Ozempic, which can be sold for less than $100 but costs nearly $1,000. Sanders calls for price reductions.
The criticism from a prominent senator like Bernie Sanders can lead to increased public and regulatory pressure on Novo Nordisk to lower its drug prices, potentially impacting its stock negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100